share_log

通化金马(000766.SZ):研制的琥珀八氢氨吖啶片是具备完全自主知识产权的I.I类国家级新药

Tonghua Golden-Horse Pharmaceutical Industry Co, Ltd (000766.SZ): The developed Amber Octahydroaminoacridine Tablets have completely independent intellectual property rights and are a Class I new drug at the national level.

Gelonghui Finance ·  Jul 30 03:52

Tonghua Golden-Horse (000766.SZ) stated on its investor platform on July 30th that our company's amber octahydroammine metronidazole tablets are a first-class new drug at the national level with completely independent intellectual property rights. The application of the active pharmaceutical ingredient for listing is an important part of the new drug listing application. Currently, the company is strictly following the relevant laws, regulations, and guidance principles of the CDE to carry out work related to the new drug listing application.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment